Brown Brothers Harriman & Co’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,524
| Closed | -$45K | – | 1521 |
|
|
2022
Q2 | $45K | Sell |
1,524
-500
| -25% | -$14.8K | ﹤0.01% | 725 |
|
|
2022
Q1 | $65K | Sell |
2,024
-7,000
| -78% | -$225K | ﹤0.01% | 717 |
|
|
2021
Q4 | $402 | Buy |
9,024
+6,524
| +261% | +$291 | ﹤0.01% | 367 |
|
|
2021
Q3 | $126 | Sell |
2,500
-3,553
| -59% | -$179 | ﹤0.01% | 528 |
|
|
2021
Q2 | $475 | Buy |
6,053
+5,000
| +475% | +$392 | ﹤0.01% | 323 |
|
|
2021
Q1 | $60 | Sell |
1,053
-17
| -2% | -$1 | ﹤0.01% | 615 |
|
|
2020
Q4 | $90K | Buy |
+1,070
| New | +$90K | ﹤0.01% | 574 |
|
|
2020
Q1 | – | Sell |
-2,316
| Closed | -$40K | – | 1144 |
|
|
2019
Q4 | $40K | Hold |
2,316
| – | – | ﹤0.01% | 705 |
|
|
2019
Q3 | $35K | Hold |
2,316
| – | – | ﹤0.01% | 704 |
|
|
2019
Q2 | $48K | Hold |
2,316
| – | – | ﹤0.01% | 591 |
|
|
2019
Q1 | $54K | Hold |
2,316
| – | – | ﹤0.01% | 563 |
|
|
2018
Q4 | $48K | Buy |
+2,316
| New | +$48K | ﹤0.01% | 517 |
|